{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:28:17Z","timestamp":1792074497315,"version":"4.4.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/rlu.0000000000001264","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T13:43:16Z","timestamp":1465566196000},"page":"e417-e419","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Impact of 68Ga-PSMA PET\/CT in a Patient With Biochemical Recurrence of Prostate Cancer"],"prefix":"10.1097","volume":"41","author":[{"given":"Marcelo A.","family":"Queiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Publio","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Etchebehere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cerri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-39-20210204","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1097\/01.ju.0000091876.13656.2e","article-title":"The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy","volume":"170","author":"Ward","year":"2003","journal-title":"J Urol"},{"key":"R2-39-20210204","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00259-013-2634-1","article-title":"Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [(11)C]choline positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer patients","volume":"41","author":"Heck","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-39-20210204","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA-ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"key":"R4-39-20210204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18 F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-39-20210204","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00330-014-3539-5","article-title":"Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm","volume":"25","author":"Vargas","year":"2015","journal-title":"Eur Radiol"},{"key":"R6-39-20210204","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00259-015-3240-1","article-title":"Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET\/CT in relation to PSA levels, PSA doubling time and Gleason score","volume":"43","author":"Verburg","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-39-20210204","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00259-015-3078-6","article-title":"68Ga-PSMA PET\/CT for restaging recurrent prostate cancer: which factors are associated with PET\/CT detection rate?","volume":"42","author":"Ceci","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-39-20210204","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-39-20210204","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/pros.22956","article-title":"Prostate-specific membrane antigen-based imaging in prostate cancer: Impact on clinical decision making process","volume":"75","author":"Demirkol","year":"2015","journal-title":"Prostate"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:15:40Z","timestamp":1620972940000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201609000-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001264","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}